Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 06:03 am Unchanged | 2019-12-06 | 13G | Molecular Data Inc. MKDTY | TB Alternative Assets Ltd. | 20,044,756 5.230% | 0 (Unchanged) | Filing History |
| 2024-02-05 9:48 pm Unchanged | 2019-12-06 | 13G | Molecular Data Inc. MKDTY | TB Alternative Assets Ltd. | 20,044,756 5.230% | 0 (Unchanged) | Filing History |
| 2023-10-05 12:01 pm Sale | 2023-10-05 | 13G | Molecular Data Inc. MKD | Streeterville Capital LLC | 35,900,305 9.990% | -11,852,842 (-24.82%) | Filing History |
| 2023-02-09 9:25 pm Purchase | 2019-12-06 | 13G | Molecular Data Inc. MKDTY | TB Alternative Assets Ltd. | 20,044,756 4.840% | 20,044,756 (New Position) | Filing History |
| 2023-02-08 06:12 am Purchase | 2019-12-06 | 13G | Molecular Data Inc. MKD | TB Alternative Assets Ltd. | 20,044,756 4.840% | 18,762,624 (+1463.39%) | Filing History |
| 2022-08-17 1:10 pm Purchase | 2022-08-17 | 13G | Molecular Data Inc. MKD | Streeterville Capital LLC | 47,753,147 9.990% | 45,359,793 (+1895.24%) | Filing History |
| 2022-02-14 11:00 am Sale | 2021-12-31 | 13G | Molecular Data Inc. MKD | SHEN NEIL NANPENG | 0 0.000% | -2,303,054 (Position Closed) | Filing History |
| 2022-02-11 07:00 am Sale | 2019-12-06 | 13G | Molecular Data Inc. MKD | TB Alternative Assets Ltd. | 1,282,132 4.640% | -423,242 (-24.82%) | Filing History |
| 2022-02-11 06:54 am Purchase | 2019-12-06 | 13G | Molecular Data Inc. MKD | TB Alternative Assets Ltd. | 1,705,375 6.180% | 152,299 (+9.81%) | Filing History |
| 2022-02-07 3:39 pm Purchase | 2021-12-31 | 13G | Molecular Data Inc. MKD | Hudson Bay Capital Management LP | 3,650,456 9.990% | 3,650,456 (New Position) | Filing History |
| 2021-04-28 06:19 am Purchase | 2020-12-31 | 13G | Molecular Data Inc. MKD | Innovation Works Development Fund II L.P. | 2,415,061 10.800% | 2,415,061 (New Position) | Filing History |
| 2021-04-15 2:29 pm Purchase | 2021-04-09 | 13G | Molecular Data Inc. MKD | Streeterville Capital LLC | 2,393,354 9.990% | 2,393,354 (New Position) | Filing History |